Keyphrases
Virus
100%
Immune Response
100%
Adenovirus
100%
Nasal
100%
Recombinant Adenovirus
100%
Prior Exposure
100%
Ebola Vaccine
100%
Formulation Development
100%
Transgene Expression
66%
Pre-existing Immunity
66%
In Vitro Assay
33%
Immunization
33%
Influenza Virus
33%
Lung Tissue
33%
Adenovirus Vaccine
33%
Vaccine Platform
33%
Partial Protection
33%
Medical Personnel
33%
Multiparameter Flow Cytometry
33%
High-risk Population
33%
Prime-boost
33%
Neutralizing Antibodies
33%
Ebola
33%
Nasal Cavity
33%
Interleukin-2
33%
Multiple Strains
33%
Full Protection
33%
Ebola Outbreak
33%
Single Immunization
33%
Poly(lactic-co-glycolic acid)
33%
Polyethylene Glycol
33%
Histochemical Analysis
33%
Polyfunctional
33%
In Vivo Performance
33%
Antigen-specific CD8+ T Cells
33%
Test Formulation
33%
Fast-acting
33%
Amphiphilic Polymer
33%
Rural Villagers
33%
Polymer Beads
33%
Immunology and Microbiology
Immune Response
100%
Adenoviridae
100%
Ebola Vaccine
100%
Transgene
33%
Infectious Agent
16%
Antigen Specificity
16%
Tumor Necrosis Factor
16%
Neutralization
16%
Cytotoxic T-Cell
16%
Neutralizing Antibody
16%
Influenza Virus
16%
Polymerization
16%
Rural Population
16%
Interleukin 2
16%
Population Risk
16%
Histochemistry
16%
Glycolic Acid
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adenoviridae
100%
Ebola Vaccine
100%
Infectious Agent
16%
Flow Cytometry
16%
Tumor Necrosis Factor
16%
Neutralizing Antibody
16%
Influenza Virus
16%
Macrogol
16%
Polyglactin
16%
Macrogol Derivative
16%
CD8 Antigen
16%
Interleukin 2
16%